Goldman Sachs Group »

Aerovate Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $151k 91k 1.66
2021-12-31 $221k 19k 11.78